Management of Chemotherapy-Induced Nausea and Vomiting New Agents and New Uses of Current Agents /
This book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for t...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Adis,
2016.
|
| Edition: | 1st ed. 2016. |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-319-27016-6 |
Table of Contents:
- 1. Introduction
- 2. The Physiology and Pharmacology of Nausea and Vomiting Induced by Anti-Cancer Chemotherapy in Humans
- 3. First Generation 5HT-3 Receptor Antagonists
- 4. Second Generation Serotonin (5-HT3) Receptor Antagonist Palonosetron
- 5. The Role of Neurokinin-1 Receptor Antagonists in CINV
- 6. Olanzapine for the prevention of Chemotherapy-Induced Nausea and Vomiting
- 7. Gabapentin for the Prevention of CINV
- 8. Prevention of CINV in Patients Receiving High-Dose Multiple-Day Chemotherapy
- 9. Clinical Management of CINV
- 10. Treatment of Chemotherapy-Induced Nausea
- 11. Conclusions
- 12. Future Directions.